RecruitingNCT04675918

Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN)

Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN): a Prospective International Multicenter Register of Cardiac Arrest in Children.

Sponsor

Jimena del Castillo

Enrollment

500 participants

Start Date

Feb 1, 2021

Study Type

OBSERVATIONAL

Conditions

Pediatric ALL Cardiac Arrest In-hospital Cardiac Arrest

Summary

: An intrahospital CA data recording protocol has been designed following the Utstein model. Database is hosted according to European legislation regarding patient data protection. It is drafted in English and Spanish. Invitation to participate has been sent to Spanish, European and Latinamerican hospitals. Variables included, asses hospital characteristics, the resuscitation team, patient's demographics and background, CPR, post-resuscitation care, mortality, survival and long-term evolution. Survival at hospital discharge will be evaluated as a primary outcome and survival with good neurological status as a secondary outcome, analyzing the different factors involved in them

Eligibility

Min Age: 1 MonthMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This international registry is collecting data on children who experience cardiac arrest (when the heart stops beating) while already in hospital. Researchers want to understand what factors affect survival and outcomes so that in-hospital cardiac resuscitation in children can be improved. **You may be eligible if you:** - Are a child between 1 month and 18 years of age - Have experienced a cardiac arrest while already in a hospital setting **You may NOT be eligible if you:** - Are being supported by an external heart-lung bypass machine (ECMO or ventricular assist device) at the time of the cardiac arrest - Had a very brief resuscitation attempt lasting less than 1 minute Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.